Sinco Pharmaceuticals Holdings Limited provided earnings guidance for the six months ended 30 June 2021. For the period, the company expects to record an increase in profit attributable to the owners of the company for the Current Period, representing an increase of not less than 115% as compared with the corresponding period in 2020, the unaudited consolidated net profit attributable to owners of the company for the six months ended 30 June 2020 amounted to approximately RMB 32.5 million. The company announced that the aforementioned increase is mainly attributable to the increase in gross profit due to the increase in sales of the Group and the effective control of operating costs and expenses of the Group.